The key point of Deltha Pharma is its Research & Development Department, which is made up of various professionals who are constantly on the lookout for new raw materials and the related tests and clinical results. Every year based on research and the needs of the population, a large number of new and innovative products are formulated. After the formulation, products samples are analysed and tested. It is only afterwards these tests are completed that production of the new supplements begins.
The raw materials used are almost solely exclusive patents and carrier substances to improve the bioavailability of the active ingredients.
In 2020, Deltha Pharma signed an agreement with the Università Cattolica del Sacro Cuore in Rome, obtaining a worldwide exclusive license for the patent of a bacterial consortium formulated by Professors at the Policlinico A. Gemelli Hospital in Rome. This is marketed under the brand name MASUROTA®.
Training and Education Seminars
The products list is presented to the medical profession by a network of highly competent and experienced medical representatives throughout the national territory.
All the information about the products to doctors is validated by a committee made of consultant’s university professors who not only verify the correctness and clarity of the presentation, but also support the marketing of the products through clinical studies carried out at the most accredited public and private health facilities.
Medical Congress
The products list is presented to the medical profession by a network of highly competent and experienced medical representatives throughout the national territory.
All the information about the products to doctors is validated by a committee made of consultant’s university professors who not only verify the correctness and clarity of the presentation, but also support the marketing of the products through clinical studies carried out at the most accredited public and private health facilities.